New FDA-Approved Diabetes Drug Slashes Heart Attack and Stroke Risk

Sci Tech Daily

Center

Factuality

Ownership

New FDA-Approved Diabetes Drug Slashes Heart Attack and Stroke Risk

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a recently FDA-approved drug for treating type 2 diabetes and kidney disease in patients with additional cardiovascular risk factors, has been shown to significantly reduce the risk of heart attack and [...]